Key result
Palmitic acid drives saturated cardiolipin accumulation, increasing mitochondrial membrane rigidity and disrupting cristae in TAZ knockout.
Why the study?
In Barth syndrome, cells lacking TAZ accumulate monolysocardiolipin and saturated cardiolipin species, but the contributions of saturated cardiolipin to mitochondrial dysfunction had not been elucidated.
This study demonstrates that saturated cardiolipins independently disrupt inner mitochondrial membrane structure and function in models of Barth syndrome, highlighting them as a potential therapeutic target.
Saturated cardiolipins may drive mitochondrial dysfunction in Barth syndrome; extends mechanistic insights but leaves open therapeutic targeting pending in vivo validation.
Cardiolipin (CL) is a four-acyl chained, mitochondrial-specific phospholipid crucial for maintenance of inner mitochondrial membrane (IMM) structure and function. In healthy tissues, CL acyl chains are highly unsaturated and maintained by a conserved remodeling pathway. However, dysregulation of CL acyl chain composition can arise from mutations in the CL transacylase, Tafazzin (TAZ), resulting in Barth syndrome (BTHS), where patients exhibit heightened mitochondrial dysfunction. Cells lacking TAZ accumulate three-acyl chained monolysocardiolipin (MLCL) as well as CL species with saturated acyl chains (CL sat ). While the presence of MLCL destabilizes electron transport chain (ETC) complexes and IMM-shaping proteins, the contributions of CL sat to mitochondrial dysfunction have not been elucidated. Here, we find that treatment of TAZ knockout cells with exogenous saturated fatty acids causes accumulation of CL sat and loss of IMM structure despite only minimal changes in MLCL composition. Imaging of cells with elevated CL sat showed reduced fluidity of the inner membrane. Biophysical measurements and molecular dynamics analyses showed that di-saturated (C16:0 18:1) 2 CL species order and rigidify membranes, while also losing the intrinsic lipid curvature characteristic of tetra-unsaturated CL. These results implicate CL sat as a potential driver of mitochondrial dysfunction and an additional therapeutic target in mitigating BTHS pathology.
No takes yet. Share an insight, caveat, or question.
Venkatraman et al. (2026) studied Barth syndrome (preclinical model). Palmitic acid vs. Oleic acid or BSA control was evaluated on Mitochondrial membrane fluidity, intrinsic curvature, and respiratory capacity. Treatment of TAZ knockout cells with palmitic acid caused accumulation of saturated cardiolipins, resulting in increased membrane rigidity and loss of inner mitochondrial membrane structure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: